Select a market to learn more.
dedicated team members
years of
market research experience
Sybil Mead is a seasoned healthcare access and reimbursement expert. With more than 20 years of experience in market access, government programs, strategic consulting, and market research, Sybil has expertise in Medicare policy, managed care, and access. She previously directed Medicare, Medicaid, and commercial payer research services, contributing to influential reports on Medicare Part D, Part B reimbursement changes, and broader policy impacts on biopharma access. Sybil holds a Master of Public Policy from the University of Chicago and a Bachelor of Arts from Cornell University.
dedicated team members
years of
continuous tracking
Sarah Soucy
Franchise Head, CNS
Sarah is a healthcare market research professional with over 10 years of experience in pharmaceutical insights and analytics. Over the course of her career, she has held leadership roles at RxY, REACH Market Research, and Decision Resources Group (Clarivate).
dedicated team members
years of
continuous tracking
Andy Stankus
Franchise Head, Dermatology
Andy, with a pharmaceutical marketing MBA, has 27+ years of experience in life sciences and healthcare consultancy creating commercial strategy, differentiation and real-world value. Prior to Spherix, Andy led global product launches at Johnson & Johnson, data and research consulting teams at Kantar Health / Oracle Life Sciences, and enjoys publishing and speaking across multiple therapeutic areas at international conferences. In addition to this broad therapeutic expertise, given a specific passion in dermatology, Andy and teams he has led have been lead authors on more than 145 dermatology publications across 20+ life sciences organizations.
dedicated team members
years of
continuous tracking
Jim Hickey
Franchise Head, Gastroenterology
dedicated team members
years of
continuous tracking
Lynn Price
Franchise Head, Rheumatology
Lynn has over eight years at Spherix, leading
strategic initiatives and insights development.
She previously, directed research analytics at
Decision Resources Group and managed
immunology research at BioTrends, with
extensive experience in data analysis and
client relations in the biopharmaceutical
sector.
dedicated team members
years of
continuous tracking
Kari has more than 20 years of experience in healthcare, strategy and insights, with a strong track record in brand development, market research, and strategic narrative building. Most recently, Kari was the VP of Strategy at DDB Health, where she led brand strategy for nephrology and oncology brands.
dedicated team members
years of
continuous tracking
Sarah Soucy
Franchise Head, Ophthalmology
Sarah is a healthcare market research professional with over 10 years of experience in pharmaceutical insights and analytics. Over the course of her career, she has held leadership roles at RxY, REACH Market Research, and Decision Resources Group (Clarivate).
dedicated team members
years of
continuous tracking
Sarah Hendry
Franchise Head, Hematology
Sarah has over a decade of experience managing custom and syndicated projects, specializing in hematology/oncology. She brings deep expertise in brand strategy and patient-centered communications within healthcare and pharma. Most recently, Sarah led brand strategy execution for CAR-T therapies at DDB Health, working closely with pharmaceutical partners to enhance engagement and brand growth. In her previous research roles at Verilogue and Maslansky + Partners, she worked extensively in hematology, including co-authoring an article in the Orphanet Journal of Rare Diseases on the lexicon for gene therapy in hemophilia B, communicating the complement cascade in PNH, and analyzing market dynamics in myeloma and B-cell malignancies.
dedicated team members
Sarah Hendry
Franchise Head, Oncology
Sarah has over a decade of experience managing custom and syndicated projects, specializing in hematology/oncology. She brings deep expertise in brand strategy and patient-centered communications within healthcare and pharma. Most recently, Sarah led brand strategy execution for CAR-T therapies at DDB Health, working closely with pharmaceutical partners to enhance engagement and brand growth. In her previous research roles at Verilogue and Maslansky + Partners, she worked extensively in hematology, including co-authoring an article in the Orphanet Journal of Rare Diseases on the lexicon for gene therapy in hemophilia B, communicating the complement cascade in PNH, and analyzing market dynamics in myeloma and B-cell malignancies.
